Gene therapy is referred to as a medical technique that involves modifying or manipulating genes to treat or prevent disease.

Krystal Biotech's VYJUVEK, a groundbreaking gene therapy for DEB, achieved $83.8M in Q3 2024 sales. Read why I rate KRYS ...

Chad Stevens traveled from Idaho to Omaha's Nebraska Medical Center, where he became the hospital's first patient to receive ...

Gene Therapy to Target GD2 for Oncology is under clinical development by Bristol-Myers Squibb and currently in Phase I for Osteosarcoma.

This seed funding comes after GEMMABio secured $100m in October through a partnership with Brazilian supplier Fiocruz.

Gene therapy, the idea of fixing faulty genes ... 5, 2024 — Researchers who work with tiny drug carriers known as lipid nanoparticles have developed a new type of material capable of reaching ...

GEMMA Biotherapeutics, founded by Jim Wilson earlier this year, will use the money to expand its operations and gene therapy ...

The new gene therapies for sickle cell disease—including the gene-editing treatment Casgevy, based on research at Boston ...

An experimental gene therapy might one day give people with heart failure a new lease on life. The therapy prompted the pigs’ ...

Astellas has licensed rights to a drug developed by Selecta Biosciences that could make more patients eligible for treatment with its gene therapy for inherited neuromuscular disorder Pompe disease.

Precision BioSciences (Nasdaq: DTIL) has received approval in Hong Kong to begin clinical trials evaluating a gene editing ...